Histogenics (HSGX) Reaches 75% Enrollment Milestone in NeoCart Phase 3
Tweet Send to a Friend
Histogenics Corporation (Histogenics) (Nasdaq: HSGX) announced that as of October 24, 2016 it had enrolled 183, or approximately three-quarters, of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE